Payers’ fail-first policies pose special concerns for clinicians treating with biologic therapies. Until these become cheaper, navigating them will ... More »
Payers’ fail-first policies pose special concerns for clinicians treating with biologic therapies. Until these become cheaper, navigating them will ... More »
The recent spike in Zika virus cases in Central and South America brings with it the alarming risk – and even the expectation – of outbreaks occur... More »
Rates of anorectal melanoma rose substantially in the United States from 1992 to 2011, according to a study published in Dermatologic Surgery.
The i... More »
Dr. Adam Friedman discussed practical methods for dealing with dermatophytes and onychomycosis that dermatologists can use in their practice.... More »
Dr. Adam Friedman discusses simple but effective ways to improve treatment of patients with atopic dermatitis at the 2016 ODAC annual meeting.... More »
SAN DIEGO – A series of radiomics-derived imaging features may improve the diagnostic accuracy of low-dose CT lung cancer screening and help predict... More »
A biomarker for which a screening test is already available – lack of CDX2 expression – appears to identify the approximately 20% of stage II and ... More »
A biomarker for which a screening test is already available – lack of CDX2 expression – appears to identify the approximately 20% of stage II and ... More »